LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR - News), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today reported financial results for the 12 months ended December 31, 2007.
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR - News), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today reported financial results for the 12 months ended December 31, 2007.